GAPP
A pilot randomised controlled trial of the efficacy and mechanism of action of gabapentin for the management of chronic pelvic pain in women.
The focus of this study is a pilot to inform planning of a future trial. The future trial will study whether gabapentin can reduce chronic pelvic pain in women who suffer from it.
Chief Investigator: Dr Andrew Horne
Number and location of participating sites (by region/ country): UK 2 sites
EudraCT number: 2014-005035-13
ISCTRN number: 70960777
Funder: CSO
Start date and end date of grant: 1 June 2012 for 21 months
Current Status: Awaiting publication
Co-sponsors: University of Edinburgh and NHS Lothian ACCORD
The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ
CI: Dr Andrew Horne, MRC Centre for Reproductive Health, The University of Edinburgh, The Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ
ECTU Involvement: Statistics